# Treatment Selection According to Skin Reaction to Cetuximab

> **NCT01472653** · PHASE2 · UNKNOWN · sponsor: **Institute of Oncology Ljubljana** · enrollment: 120 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **RADIATION:** radiotherapy
- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT01472653
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2014-03
- **Final completion:** 2016-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01472653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01472653, "Treatment Selection According to Skin Reaction to Cetuximab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01472653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*